Impact of the COVID-19 Pandemic on Healthcare Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients with Systemic Sclerosis.
Alicia CallistoDylan HansenJenny WalkerGene Siew NgianDiane ApostolopoulosDavid F L LiewVibhasha ChandCatherine L HillKim GriggsAlicia CalderoneMandana NikpourJoanne SahharWendy StevensSusanna M ProudmanPublished in: Arthritis care & research (2023)
COVID-19 pandemic-related disruption to healthcare for SSc patients was associated with worse mental health and reduced screening and diagnosis of PAH which may impact long-term outcomes. This article is protected by copyright. All rights reserved.
Keyphrases
- systemic sclerosis
- pulmonary arterial hypertension
- healthcare
- mental health
- interstitial lung disease
- end stage renal disease
- pulmonary artery
- pulmonary hypertension
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- patient reported outcomes
- mental illness
- coronary artery
- health information